ClinicalTrials.gg
CompletedNCT05987787Updated Aug 14, 2023

Suture Reinforcement to Reduce the Leak Rate After Sleeve Gastrectomy

An observational study in Bariatric Surgery Candidate, Obesity, Morbid and Leak, Anastomotic, sponsored by University of Foggia. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by University of Foggia · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
33
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Staple line reinforcement (SLR) has been suggested as a mean of reducing the risk of sleeve leakage or bleeding. The aim of this study is to analyze if the suture reinforcement can be used to reduce the leakage rate after sleeve gastrectomy.

02

Conditions studied

  • Bariatric Surgery Candidate
  • Obesity, Morbid
  • Leak, Anastomotic
  • Bleeding
03

In context

Obesity, Morbid

936 studies on the registry are indexed under Obesity, Morbid; 169 are open to participants now.

This study's enrollment of 33 is below the median of 77 across 311 observational studies indexed under Obesity, Morbid.

Browse Obesity, Morbid studies →

Lead sponsor

University of Foggia is the lead sponsor of 36 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Body mass index (BMI) ≥35-39 kg/m2 with one obesity- associated co-morbidity or BMI≥40kg/m2, age ≥ 18 years. Before surgery, patients underwent a standardized psychological and physical evaluation which includes blood chemistry tests, chest x-rays, electrocardiogram and cardiological examinations, nutritional evaluation, esophagogastroduodenoscopy, spirometry and psychiatric evaluation .

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • BMI>40 kg/m2
  • BMI>35 kg/m2with at least one associated major comorbidity

Exclusion criteria

Exclusion Criteria:

  • secondary obesity due to endocrine and psychological disorders
  • patients under antiaggregant and anticoagulant therapy
  • re-do surgery.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
33 participants (actual)
Patient registry
No

Groups and cohorts

  • Obese patients underwent laparoscopic sleeve gastrectomy with suture reinforcement

    Laparoscopic sleeve gastrectomy running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.

    Procedure: laparoscopic sleeve gastrectomy with suture reinforcement

  • Obese patients underwent laparoscopic sleeve gastrectomy without suture reinforcement

    Laparoscopic sleeve gastrectomy without staple line reinforcement.

    Procedure: laparoscopic sleeve gastrectomy without suture reinforcement

Interventions

  • Procedurelaparoscopic sleeve gastrectomy without suture reinforcement

    The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access.

  • Procedurelaparoscopic sleeve gastrectomy with suture reinforcement

    The procedure begins by dissecting the small branches of the gastroepiploic arch 6 cm from the pylorus. The dissection continues along the great curvature of the stomach, remaining very close to the gastric wall, up to the short gastric vessels which are also dissected. The stomach is then raised to expose its posterior wall and the adhesions are lysed. His angle is fully mobilized and the left diaphragmatic pillar exposed. The gastric tubule is created on the guide of a 40 F Bugie using mechanical suturing machines with charges of different thickness depending on the thickness of the gastric wall. At this point the bougie is removed and the resected stomach is extracted from the abdomen through the mesogastric access. At this point, it is applied running seromuscular stitches at the proximal third of the stapled line using unidirectional 2/0 barbed sutures to invaginate the staple line completely.

06

What researchers measure

Primary outcomes

  1. the importance of staple line reinforcement

    reduction of the leak rate in the suture group

    Time frame: 1 year

  2. the importance of staple line reinforcement

    the differences of operative time between two groups

    Time frame: During Surgery

07

Study locations

1 site
  • University of Foggia
    Foggia, 71122, Italy
08

References and documents

Study documents

  • Study protocol · Aug 2, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05987787
Lead sponsor
University of Foggia
Responsible party
Giovanna Pavone (Medical doctor, University of Foggia) — Principal investigator
First posted
Aug 14, 2023
Start date
Jan 1, 2022
Primary completion
Dec 31, 2022
Completion
Jul 1, 2023
Last update
Aug 14, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion